{"url_path":"/sec/cik-0001012477/8-k/2026-02-12/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-12","source_url":"https://www.sec.gov/Archives/edgar/data/1012477/0001104659-26-013880-index.html","accession_number":"0001104659-26-013880","cik":"0001012477","ticker":null,"issuer_name":"AVADEL PHARMACEUTICALS PLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1012477/0001104659-26-013880-index.html","primary_entity_key":"0001012477","primary_entity_name":"AVADEL PHARMACEUTICALS PLC"},"word_count":137,"has_tables":true,"body_markdown":"**Item 5.02**\n**Departure of\nDirectors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nThe information set forth in Item 2.01 is incorporated by reference\ninto this Item 5.02.\n\n \n\nIn connection with the Acquisition and as of the Effective Time, Gregory\nJ. Divis (Chief Executive Officer), Thomas S. McHugh (Chief Financial Officer), Susan Rodriguez (Chief Operating Officer) and Jerad G.\nSeurer (General Counsel and Corporate Secretary) ceased to serve in their capacities as executive officers of Avadel.\n\n \n\nAdditionally, as of the Effective Time, each of Geoffrey M. Glass,\nGregory J. Divis, Dr. Eric J. Ende, Dr. Mark A. McCamish, Linda S. Palczuk, Peter J. Thornton and Dr. Naseem S. Amin ceased\nserving as a member of the board of directors of Avadel and each committee thereof on which such director served."}